Inicio>>AP-1/NF-κB activation inhibitor 1

AP-1/NF-κB activation inhibitor 1

Catalog No.GC61970

El inhibidor de activaciÓn 1 de AP-1/NF-κB es un potente inhibidor de activaciÓn transcripcional mediado por AP-1 y NF-κB (IC50=1 μM), sin bloquear la transcripciÓn basal impulsada por el promotor de actina β.

Products are for research use only. Not for human use. We do not sell to patients.

AP-1/NF-κB activation inhibitor 1 Chemical Structure

Cas No.: 188936-12-1

Tamaño Precio Disponibilidad Cantidad
10mM (in 1mL DMSO)
198,00 $
Disponible
5 mg
180,00 $
Disponible
10 mg
270,00 $
Disponible
25 mg
495,00 $
Disponible
50 mg
765,00 $
Disponible
100 mg
1.080,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

AP-1/NF-κB activation inhibitor 1 is a potent AP-1 and NF-κB mediated transcriptional activation inhibitor (IC50=1 μM), without blocking basal transcription driven by the β-actin promoter. AP-1/NF-κB activation inhibitor 1 has a similar inhibitory effect on the production of IL-2 and IL-8 levels in stimulated cells[1].

[1]. Palanki MS, et al. Novel inhibitors of AP-1 and NF-kappaB mediated gene expression: structure-activity relationship studies of ethyl 4-[(3-methyl-2,5-dioxo(3-pyrrolinyl))amino]-2-(trifluoromethyl)++ +pyrimidi ne-5-carboxylate. Bioorg Med Chem Lett. 2000;10(15):1645-1648.

Reseñas

Review for AP-1/NF-κB activation inhibitor 1

Average Rating: 5 ★★★★★ (Based on Reviews and 39 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for AP-1/NF-κB activation inhibitor 1

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.